A tertiary care transplant center is validating a new rapid biomarker assay to detect an invasive opportunistic fungal infection in post-operative patients. According to internal hospital data, the baseline prevalence of this fungal infection among their solid organ transplant recipients is . During the validation phase, the rapid assay correctly identified of patients who had biopsy-proven fungal tissue invasion. The assay also correctly returned a negative result in of transplant recipients who were proven to be free of the infection. A 58-year-old man who recently received a renal allograft is tested as part of a routine post-operative monitoring protocol, and his biomarker assay returns a positive result. Based on the test's performance characteristics in this population, what is the probability (expressed as a percentage) that he actually has the invasive fungal infection?
Answer: 75 %